Home Cart 0 Sign in  
X

[ CAS No. 10297-73-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 10297-73-1
Chemical Structure| 10297-73-1
Chemical Structure| 10297-73-1
Structure of 10297-73-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 10297-73-1 ]

Related Doc. of [ 10297-73-1 ]

Alternatived Products of [ 10297-73-1 ]

Product Details of [ 10297-73-1 ]

CAS No. :10297-73-1 MDL No. :MFCD00025072
Formula : C9H10O3S Boiling Point : -
Linear Structure Formula :- InChI Key :KAVZYDHKJNABPC-UHFFFAOYSA-N
M.W : 198.24 Pubchem ID :82529
Synonyms :

Calculated chemistry of [ 10297-73-1 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 49.73
TPSA : 59.59 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.89 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.31
Log Po/w (XLOGP3) : 0.87
Log Po/w (WLOGP) : 2.37
Log Po/w (MLOGP) : 1.2
Log Po/w (SILICOS-IT) : 1.47
Consensus Log Po/w : 1.44

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.83
Solubility : 2.95 mg/ml ; 0.0149 mol/l
Class : Very soluble
Log S (Ali) : -1.71
Solubility : 3.91 mg/ml ; 0.0197 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.05
Solubility : 0.177 mg/ml ; 0.000891 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.49

Safety of [ 10297-73-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 10297-73-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 10297-73-1 ]
  • Downstream synthetic route of [ 10297-73-1 ]

[ 10297-73-1 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 10297-73-1 ]
  • [ 90536-66-6 ]
YieldReaction ConditionsOperation in experiment
52%
Stage #1: for 10 h; Heating / reflux
Stage #2: With sodium hydroxide In water at 84℃; for 12 h;
The synthesis was carried out as described in Scheme 2. Step a. A mixture of 4-(methylsulfonyl)acetophenone (5.5 g, 27.8 mmol), morpholine (2.5 mL), and sulfur (0.89 g, 27.8 mmol) was refluxed for 10 h, and poured into ice. The precipitated solid was filtered, and washed with cold ethyl acetate. The solid was added to 10percent sodium hydroxide (55 mL), heated to 84° C. for 12 h, and the alkaline solution was acidified with 12 N HCl. The resulting solid was filtered, dried, and recrystallized from hexane-ethyl acetate (1:1) to give 4-methylsulfonylphenylacetic acid (white solid, 4.2 g, 52percent overall yield). Step b. 2-Bromoacetophenone (1.02 g, 5.12 mmol), dissolved in acetonitrile, was added to Et3N (1.74 mL), followed by 4-methylsulfonylphenylacetic acid (1 g, 4.67 mmol). After 1.5 h at room temperature, 1,8-diazabicyclo[5,4,0]undec-7-ene (1.67 mL) was added. The reaction mixture was stirred for another 1 h, and then treated with 1 N HCl (35 mL). The product was extracted with ethyl acetate, dried over sodium sulfate, and recrystallized from ethyl acetate-hexane (1:1) to give 46b (880 mg, 60percent overall yield). 1H NMR (CDCl3) δ 3.08 (s, 3H), 5.24 (s, 2H), 7.18-7.30 (m, 5H), 7.66 (dd, J=1.9, 6.7 Hz, 2H), 7.96 (dd, J=1.9, 6.7 Hz, 2H); HRMS calc'd for M+ 314.0605, found 314.0632. Anal. (C17H14O4S)C, H.
Reference: [1] Patent: US2003/236294, 2003, A1, . Location in patent: Page 19
[2] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 5, p. 1549 - 1553
  • 2
  • [ 10297-73-1 ]
  • [ 340771-31-5 ]
Reference: [1] Organic Letters, 2017, vol. 19, # 19, p. 5118 - 5121
  • 3
  • [ 10297-73-1 ]
  • [ 162011-90-7 ]
Reference: [1] Synthesis, 2001, # 12, p. 1778 - 1779
[2] European Journal of Medicinal Chemistry, 2013, vol. 65, p. 323 - 336
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 10297-73-1 ]

Imrecoxib Related Intermediates

Chemical Structure| 622-47-9

[ 622-47-9 ]

2-(p-Tolyl)acetic acid

Related Functional Groups of
[ 10297-73-1 ]

Aryls

Chemical Structure| 5398-77-6

[ 5398-77-6 ]

4-(Methylsulfonyl)benzaldehyde

Similarity: 0.93

Chemical Structure| 43114-43-8

[ 43114-43-8 ]

3-(Methylsulfonyl)benzaldehyde

Similarity: 0.93

Chemical Structure| 50899-03-1

[ 50899-03-1 ]

4-(Ethylsulfonyl)benzaldehyde

Similarity: 0.91

Chemical Structure| 5395-89-1

[ 5395-89-1 ]

2-(Methylsulfonyl)benzaldehyde

Similarity: 0.89

Chemical Structure| 3185-99-7

[ 3185-99-7 ]

1-Methyl-4-(methylsulfonyl)benzene

Similarity: 0.82

Ketones

Chemical Structure| 1127-35-1

[ 1127-35-1 ]

Benzo[b]thiophene-3(2H)-one 1,1-Dioxide

Similarity: 0.81

Chemical Structure| 1778-09-2

[ 1778-09-2 ]

1-(4-(Methylthio)phenyl)ethanone

Similarity: 0.76

Chemical Structure| 221615-75-4

[ 221615-75-4 ]

1-(6-Methylpyridin-3-yl)-2-(4-(methylsulfonyl)phenyl)ethanone

Similarity: 0.69

Chemical Structure| 6948-34-1

[ 6948-34-1 ]

6-Methylthiochroman-4-one

Similarity: 0.67

Chemical Structure| 1531-77-7

[ 1531-77-7 ]

6,11-Dihydrodibenzo[b,e]thiepin-11-one

Similarity: 0.66

Sulfones

Chemical Structure| 5398-77-6

[ 5398-77-6 ]

4-(Methylsulfonyl)benzaldehyde

Similarity: 0.93

Chemical Structure| 43114-43-8

[ 43114-43-8 ]

3-(Methylsulfonyl)benzaldehyde

Similarity: 0.93

Chemical Structure| 50899-03-1

[ 50899-03-1 ]

4-(Ethylsulfonyl)benzaldehyde

Similarity: 0.91

Chemical Structure| 5395-89-1

[ 5395-89-1 ]

2-(Methylsulfonyl)benzaldehyde

Similarity: 0.89

Chemical Structure| 3185-99-7

[ 3185-99-7 ]

1-Methyl-4-(methylsulfonyl)benzene

Similarity: 0.82